Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia.
J Extracell Vesicles. 2021 Nov;10(13):e12164. doi: 10.1002/jev2.12164.
The extracellular vesicle (EV) surface proteome (surfaceome) acts as a fundamental signalling gateway by bridging intra- and extracellular signalling networks, dictates EVs' capacity to communicate and interact with their environment, and is a source of potential disease biomarkers and therapeutic targets. However, our understanding of surface protein composition of large EVs (L-EVs, 100-800 nm, mean 310 nm, ATP5F1A, ATP5F1B, DHX9, GOT2, HSPA5, HSPD1, MDH2, STOML2), a major EV-subtype that are distinct from small EVs (S-EVs, 30-150 nm, mean 110 nm, CD44, CD63, CD81, CD82, CD9, PDCD6IP, SDCBP, TSG101) remains limited. Using a membrane impermeant derivative of biotin to capture surface proteins coupled to mass spectrometry analysis, we show that out of 4143 proteins identified in density-gradient purified L-EVs (1.07-1.11 g/mL, from multiple cancer cell lines), 961 proteins are surface accessible. The surface molecular diversity of L-EVs include (i) bona fide plasma membrane anchored proteins (cluster of differentiation, transporters, receptors and GPI anchored proteins implicated in cell-cell and cell-ECM interactions); and (ii) membrane surface-associated proteins (that are released by divalent ion chelator EDTA) implicated in actin cytoskeleton regulation, junction organization, glycolysis and platelet activation. Ligand-receptor analysis of L-EV surfaceome (e.g., ITGAV/ITGB1) uncovered interactome spanning 172 experimentally verified cognate binding partners (e.g., ANGPTL3, PLG, and VTN) with highest tissue enrichment for liver. Assessment of biotin inaccessible L-EV proteome revealed enrichment for proteins belonging to COPI/II-coated ER/Golgi-derived vesicles and mitochondria. Additionally, despite common surface proteins identified in L-EVs and S-EVs, our data reveals surfaceome heterogeneity between the two EV-subtype. Collectively, our study provides critical insights into diverse proteins operating at the interactive platform of L-EVs and molecular leads for future studies seeking to decipher L-EV heterogeneity and function.
细胞外囊泡 (EV) 表面蛋白质组 (表面组) 作为细胞内和细胞外信号网络之间的基本信号转导门户,决定了 EV 与环境进行通讯和相互作用的能力,并且是潜在疾病生物标志物和治疗靶点的来源。然而,我们对大细胞外囊泡 (L-EV,100-800nm,平均 310nm,ATP5F1A、ATP5F1B、DHX9、GOT2、HSPA5、HSPD1、MDH2、STOML2) 的表面蛋白组成的理解仍然有限,L-EV 是一种与小细胞外囊泡 (S-EV,30-150nm,平均 110nm,CD44、CD63、CD81、CD82、CD9、PDCD6IP、SDCBP、TSG101) 不同的主要 EV 亚型。我们使用一种不可渗透细胞膜的生物素衍生物来捕获与质谱分析偶联的表面蛋白,结果表明,在密度梯度纯化的 L-EV(来自多种癌细胞系,1.07-1.11g/mL) 中鉴定出的 4143 种蛋白质中,有 961 种是可接触的表面蛋白。L-EV 的表面分子多样性包括:(i) 真正的质膜锚定蛋白(分化簇、转运蛋白、受体和 GPI 锚定蛋白,参与细胞-细胞和细胞-细胞外基质相互作用);和 (ii) 膜表面相关蛋白(由二价离子螯合剂 EDTA 释放),参与肌动蛋白细胞骨架调节、连接组织、糖酵解和血小板激活。L-EV 表面组的配体-受体分析(例如 ITGAV/ITGB1) 揭示了跨越 172 个经实验验证的同源结合伙伴(例如 ANGPTL3、PLG 和 VTN)的相互作用组,这些伙伴在肝脏中的组织丰度最高。对生物素不可及的 L-EV 蛋白质组的评估显示,富含属于 COPI/II 包被的内质网/高尔基体衍生囊泡和线粒体的蛋白质。此外,尽管在 L-EV 和 S-EV 中都鉴定出了常见的表面蛋白,但我们的数据揭示了这两种 EV 亚型之间的表面组异质性。总的来说,我们的研究为 L-EV 相互作用平台上的各种蛋白质提供了重要的见解,并为未来试图解析 L-EV 异质性和功能的研究提供了分子线索。